medigraphic.com
ISSN 0016-3813 (Print)

2018, Number 1

<< Back Next >>

Gac Med Mex 2018; 154 (1)

Etiología de las vasculitis cutáneas: utilidad de una aproximación sistémica

Chanussot-Deprez C, Vega-Memije ME, Flores-Suárez L, Ríos-Romero C, Cabiedes-Contreras J, Reyes E, Rangel-Gamboa L

Language: Spanish
References: 39
Page: 62-67
PDF size: 231.18 Kb.


ABSTRACT

Cutaneous vasculities (CV) represents a diagnostic challenge, occurs as primary cutaneous disorder or as a manifestation of other entities. Objective: To search the cause of CV. Methods: Patients with CV were prospectively evaluated. In all patients, skin biopsies were drawn, and direct immunofluorescence was done in most of the patients. American College of Rheumatology (ACR) and Chapel Hill Consensus Conference Criteria (CHCC) were used for classification. Results: 32 patients were studied. There was female predominance (71.8%). Children presented drug-associated CV or Schönlein-Henoch púrpura (SHP). Adults presented more frequently SHP, systemic lupus erythematosus or paraneoplastic vasculitis, other diagnosis as polyarteritis nodosa, microscopic polyangiitis, thrombotic vasculitis (post-puerperal), antiphospholipid syndrome, Churg-Strauss syndrome, and drug-associated CV were presented. Using the ACR and CHCC criteria, 50% of cases were classified. Discussion: In our institution, during this work the etiologic diagnostic of CV increased more than twice. However, in the case of HSV or LA and SHP none of the proposed criteria had high specificity; other parameters were used to discern between both. Six patients remained as not classified. In our view, cryoglobulins and hepatitis serology do not seem useful unless patient’s history supports they need to be done. Unclassified patients were followed-up closely for 2 years.


REFERENCES

  1. Gonzalez-Gay MA, Garcia-Porrua C, Pujol RM. Clinical approach to cutaneous vasculitis. Curr Opin Rheumatol. 2005;17(1) 56-61.

  2. Sneller M, Fauci A. Pathogenesis of vasculitis sindromes. Med Clin North Am. 1997;81(1):221-42.

  3. Ramirez GA, Weyand C, Vaglio A, et al. Editorial: Vascular inflammation in systemic autoimmunity. Front Immunol. 2016;21(7):471.

  4. Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol. 2008;9(2):71-92.

  5. Blanco R, Martínez-Taboada V, Rodríguez-Valverde V. Cutaneous vasculitis in children and adults: associated diseases and etiologic factors in 303 patients. Medicine. 1998;77(6):403-18.

  6. Crowson AN, Mihm M, Magro C. Cutaneous vasculitis: a Review. J Cutan Pathol. 2003;30(3):161-73.

  7. Bloch DA, Michel BA, Hunter GG, et al. The American College of Rheumatology. Development of classification and response criteria for the classification of vasculitis, patients and methods. Arthritis Rheum. 1990;2990(33):1068-73.

  8. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthris Rheuma. 2013;65:1-11.

  9. Luqmani RA, Suppiah R, Grayson PC, et al. Nomenclature and classification of vasculitis – update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS). Clin Exp Immunol. 2011;164(suppl1): 11-3.

  10. Töpel I, Zorger N, Steinbauer M. Inflammatory diseases of the aorta. Gefässchirurgie 2016;21(Suppl 2):S80-6.

  11. Dillon MJ, Eleftheriou D, Brogan P. Medium-size-vessel vasculitis. Pediatr Nephrol 2010;25(9):1641-52.

  12. Wojciechowska J, Krajewski W, Krajewski P, et al. Granulomatosis with polyangiitis in otolaryngology. Clin Experimen Otor. 2016;9(1):8-13.

  13. Benallegue N, Lozach P, Belizna C, et al. Acute coronary vasospasm in a patient with eosinophilic granulomatosis with polyangitis following NSAID administration: A case report. Medicine (Baltimore). 2016;95(47) e5259.

  14. García-Nava M, Mateos-Toledo H, Guevara-Canseco AP, et al. Early interstitial lung disease in microscopic polyangiitis: case report and literature review. Reumatol Clin. 2016;2:S1699-258X(16)30132-2.

  15. Hong J, Yang HR, Laboratory markers indicating gastrointestinal involvement of Henoch-Schönlein purpura in children. Pediatr Gastroenterol Hepatol Nutr. 2015;18(1):39-47.

  16. Monjazeb S, Philips RC, Wilkerson M. A case of leukocytoclastic vasculitis following influenza vaccination. JAAD Case Rep. 2016;17(4):340-2.

  17. Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65:936-41.

  18. Diplomatico M, Gicchino MF, Ametrano O, et al. A case of urticarial vasculitis in a female patient with lupus: Mycoplasma pneumoniae infection or lupus reactivation? Rheumatol Int. 2017;37(5):837-40.

  19. Sáenz de Santa María M, Morales-Cabeza C, Noguerado-Mellado B, et al. Cutaneous leukocytoclastic vasculitis due to amoxicillin hypersensitivity. Ann Allergy Asthma Immunol. 2016;117(4):446-7.

  20. Lee SH, Kim JH, Park S, et al. Pulmonary leukocytoclastic vasculitis as an initial presentation of myelodysplastic syndrome. Tuberc Respir Dis. 2016;79(4):302-6.

  21. Ruelas Villavicencio AL, García Hidalho L, Reyes Gutiérrez E, et al. Causas de vasculitis cutánea en 59 pacientes mexicanos. Experiencia de un centro de tercer nivel. Dermatología Rev Mex. 2011;55(6):334-1.

  22. Carlson A. The histological assessment of cutaneous vasculitis. Histopathology. 2010;56:3-23.

  23. Pulido-Pérez A, Avilés-Izquierdo JA Suárez-Fernández R. Vasculitis cutáneas. Actas Dermosiiliogr. 2012;103(3):179-91.

  24. Carlson A, Ng BT, Chen KR. Cutaneous vasculitis update: Diagnostic criteria classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol. 2005;27:504-28.

  25. Fiorentino D. Cutaneous vasculitis. J Am Acad Dermatol. 2003; 48(3):311-40.

  26. Al-Mutairi N. Spectrum of cutaneous vasculitis in adult patients from the Fawiniya region of Kuwait. Med Princ Pract. 2008;17(1):43-8.

  27. Gibson L. Cutaneous vasculitis update. Dermatol Clin. 2001;19(4):603-15.

  28. Kawakami T, Yamazaki M, Mizoguchi M, et al. High titer of serum antiphospholipid antibody levels in adult Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis. Arthritis Rheum. 2008;59(4):561-7.

  29. Davin JC, Weening J. Diagnosis of Henoch-Schönlein purpura: renal or skin biopsy? Ped Nephrol. 2003;1201-3.

  30. Oh C, Lee SH, Heo CP. A case suggesting lymphocytic vasculitis as a presenting sign of early undifferenciated connective tissue disease. Am J Dermatopathol. 2003;25(5):423-7.

  31. Monach PA. Biomarkers in Vasculitis. Curr Opin Rheumatol. 2014; 26(1):24-30.

  32. Wiik A. Rational use of ANCA in the diagnosis of vasculitis. Rheumatol. 2002;41:481-3.

  33. Mohan N, Kerr G. Diagnosis of vasculitis. Best Pact Research Clin Rheumatol. 2001;15(2):203-23.

  34. Barnadas M, Perez E, Gich I. Diagnostic, prognostic and pathogenic value of the direct immunofluorescence test in cutaneous leucocytoclastic vasculitis. Int J Dermatol. 2004;43:19-26.

  35. Fervenza F. Henoch-Schönlein purpura nephritis. Int J Dermatol. 2003;42:170-7.

  36. Crowson A, Magro C, Usmani A, et al. Immunoglobulin A-associated lymphocytic vasculopathy: a clinicopathologic study of eight patients. J Cutan Pathol. 2002;29:596-601.

  37. Sano H, Izumida M, Shimizu H. Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura. Eur J Pediatr. 2002:196-201.

  38. Davin JC, Weening J. Henoch-Schönlein purpura: an update. Eur J Pediatr. 2001:689-95.

  39. Craven A, Robson J, Ponte C, et al. ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS). Clin Exp Nephrol. 2013;17:619-21.




2020     |     www.medigraphic.com